The Texas House of Representatives has given initial approval to a bill that would significantly expand the state’s medical marijuana program.
After clearing committee last week, the bipartisan legislation from Reps. Ken King (R) and Penny Morales Shaw (D) passed the full House on second reading in a 118-16 vote on Monday. It will need a final third reading vote before potentially moving to the Senate.
The measure would expand the types of products patients could buy and also add multiple qualifying conditions for people to become registered patients.
“Back in 2015, Texas passed the Compassionate Use Act that allowed patients with epilepsy to access low-THC cannabis. Since then, the program has been expanded to include additional medical conditions, but Texans still struggle to get access to the medicine they’re legally allowed to receive,” King said on the floor. “There are not enough dispensing organizations licensed in the state, and current law limits how and where the products can be stored and distributed.”
Specifically, the measure would allow patients to access cannabis patches, lotions, suppositories, approved inhalers, nebulizers and and vaping devices. The currently limited list of qualifying conditions would be extended to include chronic pain, glaucoma, traumatic brain injury (TBI), spinal neuropathy, Crohn’s disease or other inflammatory bowel disease, degenerative disc disease and any terminal illness for patients receiving hospice or palliative care.
Military veterans would be able to become registered cannabis patients for any medical condition, and the Texas Department of State Health Services (DSHS) would also be authorized for further expand the list.
HB 46 would additionally mandate that the Department of Public Safety (DPS) issue 11 dispensary licenses within the 11 designated public health regions across the state. It would further allow dispensaries to open satellite locations if approved.
An amendment that was adopted on the floor would grandfather existing medical cannabis satellite locations, amend the patient application process, ensure that cannabis potency dosages are determined by their physicians, create a timeline for when new licenses must be issued, remove a 1.2 gram limit for possession by patients and instead allow doctors to prescribe an amount they see fit.